This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
B cell (Raji)
Blood
Bone marrow stromal cells
Caput luminal fluid
Cauda epithelial cell
Cauda luminal fluid
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Leukemia cell (K562)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Malignant melanoma cell (A375)
Multiple myeloma cells (KMS-11)
Multiple myeloma cells (RPMI8226)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Plasma
Serum
T cell (Jurkat)
By sample status
Healthy_timepoint1
Healthy_timepoint2
Multiple myeloma patients
Normal
Normal_Agilent
Normal_Exiqon
Normal_old
Pancreatic cancer patient_Agilent
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Sample A_Biooscientific
Sample A_Illumina
Sample A_NEB
Sample B_Biooscientific
Sample B_NEB
Sample C_NEB
Survived under long-term hypoxia
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-874-3p
MIMAT0004911
2.8e-4
3.9e-1
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
2.9e-5
3.0e-1
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
6.5e-7
4.9e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
1.9e-5
5.0e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
5.0e-14
4.4e-1
Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
3.7e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
4.2e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
4.7e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
3.6e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
4.1e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
4.4e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
3.9e-1
Epididymosomes convey different repertoires of microRNAs throughout the bovine epididymis.
Biol Reprod. 2013 Aug 15;89(2):30. doi: 10.1095/biolreprod.113.110486. Print 2013 Aug.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
2.6e-1
Epididymosomes convey different repertoires of microRNAs throughout the bovine epididymis.
Biol Reprod. 2013 Aug 15;89(2):30. doi: 10.1095/biolreprod.113.110486. Print 2013 Aug.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
2.8e-1
Epididymosomes convey different repertoires of microRNAs throughout the bovine epididymis.
Biol Reprod. 2013 Aug 15;89(2):30. doi: 10.1095/biolreprod.113.110486. Print 2013 Aug.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
3.5e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
3.8e-2
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
2.6e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
2.7e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
5.5e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
3.8e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
9.7e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
3.3e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
4.0e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
3.9e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
2.5e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
2.7e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
2.0e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
0.0e+0
4.8e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
2.0e-3
2.0e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000401_2
44
/
0
/
44
hsa-miR-874-3p
MIMAT0004911
6.4e-3
6.4e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000401_2
44
/
0
/
44
[1]